ArticleBlood cancer discovery2021

Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy.

Sima Jeha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.